Live tape
Top 8, mentions 7d6,975GOOGL1,565 mentions▲ +0.03NKE1,412 mentions▲ +0.03META1,012 mentions▲ +0.05NVDA884 mentions▲ +0.09TSLA603 mentions▲ +0.05MSFT512 mentions▲ +0.04AMZN495 mentions▲ +0.06RBA492 mentions▲ +0.05

Equity · Healthcare

CNMD

NYSE

CONMED Corporation

$46.23 −1.65% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 30, 2026
Price · Chart
Our own end-of-day closes 31 sessions
$50 $30 6 Jul 30 Sep

The line runs $35 on 6 July through $46.23 on 30 September, on a scale from $30 to $50. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of CNMD over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 31 sessions over that window: $35 on 6 July 2026 through $46.23 on 30 September 2026.

Market cap $1.4B
P/E (TTM) 30.6
52-week range $32 – $49
Avg volume 119.4K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 30, 2026

CNMD insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 8 Sep 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 1

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
08 Sep 2026 Kelderman Kim Director Option exercise 500

CNMD reported financials

SEC EDGAR XBRL

CNMD reported revenue of $1.4B for the fiscal year ended 31 Dec 2025. Net income over the same period was $47.1M.

Figure Reported Period
Revenue $1.4B 31 Dec 2025 fiscal year
Net income $47.1M 31 Dec 2025 fiscal year
Diluted EPS $1.51 31 Dec 2025 fiscal year
Total assets $2.3B 30 Jun 2026 at period end
Total equity $1.0B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CNMD earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.77 $343M
31 Dec 2025 FY 2025 $1.51 $1.37B
30 Sep 2025 Q3 2025 $0.09 $338M
30 Jun 2025 Q2 2025 $0.69 $342M
31 Mar 2025 Q1 2025 $0.19 $321M
31 Dec 2024 FY 2024 $4.25 $1.31B
30 Sep 2024 Q3 2024 $1.57 $317M
30 Jun 2024 Q2 2024 $0.96 $332M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CNMD institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a CNMD position for the quarter ended 30 Jun 2026 — a combined $54.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Two Sigma Investments Held (±25%) −6.8% shares 728,976 $23.9M
AQR Capital Management Added +250.1% shares 280,916 $9.2M
Marshall Wace Held (±25%) +2.8% shares 175,454 $5.7M
Citadel Advisors Trimmed −42.4% shares 142,263 $4.7M
Millennium Management Added +51.0% shares 114,609 $3.8M
Point72 Asset Management Trimmed −48.1% shares 69,585 $2.3M
D. E. Shaw & Co. Added +42.4% shares 68,134 $2.2M
GAMCO Investors Held (±25%) 57,200 $1.9M
Tudor Investment Corp New position 23,303 $763K
Balyasny Asset Management Exited

Source: SEC EDGAR 13F filings

CNMD fails-to-deliver

SEC CNS data

On 10 Sep 2026, 3,268 shares of CNMD failed to deliver (about $153K).

Settlement date Shares failed Notional % of shares out
10 Sep 2026 3,268 $153K 0.011%
31 Aug 2026 464 $23K 0.002%
19 Aug 2026 381 $19K 0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in CNMD

STOCK Act disclosures

The most recent congressional trade disclosed in CNMD is a purchase by David J. Taylor (house, OH), dated 15 Feb 2019.

Date Member Type Amount
15 Feb 2019 filed 14 Mar 2019 David J. Taylor house · Republican–OH Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures